Hence, pairing glucagon and thyroid hormones as a peptide-drug conjugate provides efficacious management of multiple elements in the metabolic syndrome, including hyperglycemia, obesity, fatty liver disease, and atherosclerosis. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.